Skip to main content

Month: May 2020

Monthly disclosure on share capital and voting rights April 30, 2020

REGULATED INFORMATIONMONTHLY DISCLOSURE ON SHARE CAPITAL AND VOTING RIGHTSPursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorités des Marchés FinanciersIssy-les-Moulineaux, May 5, 2020Registered name of the issuer: SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUX*     Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights.**    Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having either single or double voting rights, including treasury shares which would normally be temporarily deprived of voting rights.About SodexoFounded in...

Continue reading

Déclaration mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2020

 INFORMATION REGLEMENTEEDECLARATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIALArticle L.233-8-II du Code de commerce et article 223-16 du Règlement général de l’AMFIssy-les-Moulineaux, le 5 mai 2020Dénomination sociale de l’émetteur : SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUX*     Toutes les actions de la Société disposent des mêmes droits de vote, à l’exception des actions auto-détenues qui sont privées de droits de vote et des actions détenues sous la forme nominative depuis quatre ans au moins qui bénéficient de droits de vote doubles.**    Le nombre de droits de vote théoriques est calculé sur la base de l’ensemble des actions auxquelles sont attachés des droits de vote (simple ou double), y compris les actions temporairement privées de droits de vote...

Continue reading

Flow Capital Announces Chief Investment Officer’s Transition

TORONTO, May 05, 2020 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital” or the “Company”) announces the departure of Robb McLarty from his role as Chief Investment Officer of the Company as he leaves to pursue other opportunities.    “Robb has made significant contributions to our business. I would like to thank him for his hard work and dedication and wish him every success in the future,” said Alex Baluta, CEO of Flow Capital.Mr. McLarty will be staying with the Company until Friday, May 22, during which period he will transition the Chief Investment Officer responsibilities to Alex Baluta.About Flow CapitalFlow Capital Corp. is a diversified alternative asset investor and advisor, specializing in providing minimally dilutive capital to emerging growth businesses. To apply for financing, visit www.flowcap.com.For...

Continue reading

Gold X Mining – Fast Track to Production Decision

Extensive work of over 20 years and US$150 million invested allows for focus turning to “race to production” strategy under new management lead by Paul Matysek CEO and Chairman Fully funded to fast track Feasibility and Permitting work which has commenced Life of Mine Free Cash Flow of US$1.77B, 27.68% after-tax IRR, and 2 year payback of US$378 M pre-production capital expense (US$272 M net Capex assuming Wheaton participation and construction deposits) are estimated in the TEM at a US$1,500 / per ounce gold price defined In the 2019 Preliminary Economic Assessment (the “PEA”)1VANCOUVER, British Columbia, May 05, 2020 (GLOBE NEWSWIRE) — Gold X Mining Corp. (TSX-V: GLDX, OTCQX: SSPXF) (“Gold X” or the “Company”) is pleased to provide an update of its activities on the Toroparu Project in Guyana.Following recent changes to the Management...

Continue reading

CENTOGENE Announces Global Expansion of COVID-19 Testing

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN,, May 05, 2020 (GLOBE NEWSWIRE) — CENTOGENE (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today announced it will expand its testing efforts for the novel coronavirus, or COVID-19. The Company was previously testing in Germany’s Mecklenburg-Western Pomerania region, and will now be offering its extensively validated SARS-CoV-2 RT-PCR testing to the rest of the world. This announcement comes as one of the Company’s latest initiatives to support the earliest possible diagnosis of COVID-19 and prevent a further outbreak.CENTOGENE Senior Vice President of Clinical Lab Operations and Head of the Hamburg Laboratory Dr. Florian Vogel...

Continue reading

Curative Biosciences Announces New Line of THC-Free CBD Softgels

MIAMI, May 05, 2020 (GLOBE NEWSWIRE) — Curative Biosciences, Inc., (CBDX) (“Curative”) announced today the launch of its new line of Full-Spectrum CBD Oil Softgels.  Curative’s pharmaceutical grade hemp-derived CBD Softgels contain 10mg and 25mg per softgel and will be offered in bottles containing 300mg, 600mg, 750mg, and 1,500mg of CBD. Curative’s CBD Oil Softgels are whole-plant extracts containing a full-spectrum of naturally occurring synergistic cannabinoids and terpenes.  The product benefits include:Zero THCFully AbsorbableOptimum BioavailabilityFull-Spectrum CannabinoidsGMP/NSF ManufacturedLab-tested for Quality and PurityMade in the USAThe introduction of this new of line CBD Oil Softgels allows Curative Biosciences to meet the growing demand for CBD oil products in the United States, Canada and 60+ other countries.  BDS...

Continue reading

Inhibitory Effect of Innovation Pharmaceuticals’ Brilacidin on SARS-CoV-2 (COVID-19) in Primary Human Immune Cells to be Studied at Leading Public Health Research Institute

WAKEFIELD, Mass., May 05, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has executed a Material Transfer Agreement (MTA) with a leading U.S.-based Public Health Research Institute, with access to a Biosafety Level-3 (BSL-3) laboratory, to evaluate the immunomodulatory and antiviral properties of Brilacidin in relation to COVID-19. This new research is separate from the previously announced antiviral studies being conducted at a U.S. Regional Biocontainment Laboratory (RBL), which over the weekend informed us that the next phase of Brilacidin testing has commenced.Scientists at the Public Health Research Institute plan to evaluate Brilacidin’s inhibitory effect on SARS-CoV-2 viral replication in primary immune mediators (peripheral...

Continue reading

The York Water Company Reports Three Months Earnings

YORK, Pa., May 05, 2020 (GLOBE NEWSWIRE) — The York Water Company’s (NASDAQ:YORW) President, JT Hand, announced the Company’s financial results for the first quarter of 2020.President Hand reported that first quarter operating revenues of $12,877,000 increased $1,046,000, and net income of $4,002,000 increased $1,189,000 compared to the first quarter of 2019.  Basic and Diluted Earnings per share of $0.31 for the three-month period increased $0.09 compared to the same period last year.  Increased revenues were primarily due to an increase in rates effective March 1, 2019 partially offset by a reset to zero of the Distribution System Improvement Charge (DSIC).  DSIC is a Pennsylvania Public Utility Commission (PPUC) allowed charge that water utilities collect from customers for the replacement of aging infrastructure. ...

Continue reading

Touchpoint Group Holdings to Launch Dedicated E-Sports Streaming Platform Supported by Licensing Agreements and Digital Advertising

E-Sports attracting substantial digital advertising dollars during COVID-19 pandemicPlatform designed to provide robust streaming demanded by E-Sports gaming teams or “clans” to maximize visualization, audio and connectivity at high Frames Per Second (FPS) and Refresh Rate (Hz)Artificial Intelligence (AI) technology to drive E-Sports app personalization capabilitiesMIAMI, May 05, 2020 (GLOBE NEWSWIRE) — Touchpoint Group Holdings, Inc. (OTCQB: TGHI), a media and digital technology holding company that designs intelligent mobile app solutions for the live streaming of content, today announced that it is launching an innovative, dedicated platform for E-Sports designed specifically to meet the evolving demands of gamers and their fans. The platform, built in consultation with gamers and fans, will allow for unprecedented customization...

Continue reading

Articles of Association for Ringkjøbing Landbobank A/S

Articles of Associationfor Ringkjøbing Landbobank A/SCompany reg. (CVR) no. 375368144 March 2020Name, registered office and objectArt. 1The bank’s name shall be ”Ringkjøbing Landbobank, Aktieselskab”. The bank’s domicile shall be the municipality of Ringkøbing-Skjern.The bank’s object shall be to carry out banking business and other activities permitted by the relevant legislation in order to create a sound and healthy bank for its sphere of activities via solid and cost-efficient operations.The bank shall also operate under the secondary names of:• Nordjyske Bank A/S• A/S Egnsbank Nord• Folkebanken for Frederikshavn og Omegn Aktieselskab• Aktieselskabet Frederikshavns Bank• Aktieselskabet Skagens Bank• Aktieselskabet Sæby Bank• Vendsyssel Bank A/S• A/S Handels- og Landbrugsbanken i Hjørring• Lokalbanken i Hjørring A/S• Lokalbanken i...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.